Cardiac Marker Analyzer Market & Product Analysis, By Analyzers (Alere Meterpro Analyzer, RAMP 200, RAMP Reader, etc) & Companies
Global Cardiac Marker Analyzer Market is projected to cross US$ 4 Billion by the year 2024. Cardiac Marker Analyzer (Cardiac Reader Systems) offers high point of care testing results for the diagnosis of cardiac related diseases like myocardial infarction and others. Cardiac Marker Analyzer performs all cardiac monitoring tests such as Troponin, Myoglobin, CK-MB and D-Dimer tests, through immunochromatographic assays. Cardiac marker analyzer efficiency and accuracy can be increased with the help of dedicated software and system which offers extensive support to diagnostic procedures and built in LCD displays for the visualization of practices.
Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways – to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.
Some of the major Cardiac Marker Analyzers which are frequently used in the diagnosis of patient’s cardiac conditions include i–STAT System, RAMP Reader, RAMP 200, QL Care Analyzer, Access 2 Immunoassay System, Meritas POC Analyzer, Alere Meterpro Analyzer, PATHFAST Analyzer, Stratus CS Analyzer, Cobas H 232 POC System, ichroma DUO Analyzer and DXpress Reader Analyzer.
Cardiac Marker Analyzers plays an important role in the prevention of the misdiagnoses of heart conditions. Increasing prevalence of heart related diseases across the globe and growing awareness among people about the cardiovascular diseases is expected to drive the demand of Cardiac Marker Analyzers for the diagnosis of cardiac diseases.
Renub Research report titled “Cardiac Marker Analyzer Market & Product Analysis, By Analyzers (Alere Meterpro Analyzer, RAMP 200, RAMP Reader, The i–STAT System, cobas h 232 POC System, Stratus CS Analyzer, Access 2 Immunoassay System, ichroma DUO Analyzer, DXpress Reader Analyzer, PATHFAST Analyzer, Meritas POC Analyzer, QL Care Analyzer), Companies (Abbott Laboratories, Getein Biotechnology, Siemens Healthcare, Beckman-Coulter, Alere, Response Biomedical, Roche Diagnostics, Boditech, LifeSign, LSI Medience Corporation, Trinity Biotech, CardioGenics)” provides a complete analysis of Cardiac Marker Analyzer Products.
All the 12 Cardiac Marker Analyzers in the report have been studied from 6 viewpoints.
1. Cardiac Marker Analyzer Market
2. Analyzer Specifications and Benefits
3. Net Product Sales
4. Merger, Acquisition & Licensing Agreement
5. Marketing Strategies
6. Methods of Distribution
12 Cardiac Marker Analyzer studied in the report are as follows:
1. Alere Meterpro Analyzer
2. RAMP 200
3. RAMP Reader
4. The i–STAT System
5. cobas h 232 POC System
6. Stratus CS Analyzer
7. Access 2 Immunoassay System
8. ichroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. Meritas POC Analyzer
12. QL Care Analyzer
Company Analysis
• Abbott Laboratories
• Getein Biotechnology
• Siemens Healthcare
• Beckman-Coulter
• Alere
• Response Biomedical
• Roche Diagnostics
• Boditech
• LifeSign
• LSI Medience Corporation
• Trinity Biotech
• CardioGenics
- 1. Executive Summary
- 2. Cardiac Marker Analyzer Market (2011 – 2024)
- 3. Cardiac Marker Companies – Comparative Tests Analysis
- 4. Cardiac Marker Analyzer – Competitive Product Analysis
- 5. Alere
- 5.1 Alere Triage
- 5.1.1 Triage MeterPro Analyzer
- 5.2 Alere Cardiology Net Sales & Forecast (2011 - 2022)
- 6. Response Biomedical
- 6.1 Cardiovascular Testing
- 6.1.1 Acute Myocardial Infarction (Heart Attack) Testing
- 6.1.2 Congestive Heart Failure (“CHF”) Testing
- 6.1.3 Thrombotic Disease Testing
- 6.2 RAMP Platform
- 6.2.1 RAMP 200
- 6.2.2 RAMP Reader
- 6.3 Response Biomedical Cardiovascular Net Sales
- 7. Abbott Point of Care
- 7.1 The i–STAT System
- 7.2 Abbott Laboratories Point of Care Diagnostics Sales (2011 – 2024)
- 8. Roche
- 8.1 Cobas h 232 POC System
- 9. Siemens Healthineers
- 9.1 Stratus CS Analyzer
- 9.2 Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare
- 10. Beckman Coulter
- 10.1 Access 2 Immunoassay System
- 11. Boditech
- 11.1 i–chroma DUO Analyzer
- 12. Lifesign
- 12.1 DXpress Reader Analyzer
- 13. LSI Medience Corporation
- 13.1 PATHFAST Analyzer
- 14. Trinity Biotech
- 14.1 Meritas POC Analyzer
- 14.2 Trinity Biotech Point of Care Diagnostics Sales (2011 – 2024)
- 15. CardioGenics Holdings Inc.
- 15.1 QL Care Analyzer
- 16. Mergers, Acquisitions and Licensing Agreements
- 16.1 Alere Inc
- 16.2 Response Biomedical
- 16.3 Abbott Laboratories
- 16.4 Siemens Healthineers
- 16.5 LSI Medience Corporation
- 16.6 Trinity Biotech
- 16.7 CardioGenics
- 17. Emerging Markers
- 18. Response Biomedical – Business & Marketing Strategy
- 18.1 Reducing Research & Development (R&D) and Sales & Marketing Expenses under the Cost Reduction Strategy
- 18.2 New Distributors in China
- 18.3 Strategic Alliances with Alere Medical in Japan
- 18.4 Response Biomedical Receives Health Canada Approval and CE Mark
- 19. Roche – Business & Marketing Strategy
- 19.1 Implementing the Fully Connected Core Laboratory
- 19.2 Expansion of Rich Test Menu
- 19.3 Broadening the Diagnostics Portfolio
- 19.4 Patient Safety Comes First
- 20. Siemens Healthineers – Business and Marketing Strategy
- 20.1 Siemens Healthineers Announces New Strategic Relationship
- 20.2 Cloud-Based Network Teamplay from Siemens Healthineers
- 20.3 Strategic Partnership between Siemens and Imricor
- 20.4 Siemens Healthineers Offers True High-Sensitivity Troponin I IVD Assay
- 20.5 Siemens Healthineers & Digitalization
- 20.6 Partnership between Siemens Healthineers and Ebit
- 21. Boditech Med Inc – Business and Marketing Strategy
- 21.1 Boditech Med Acquires Immunostics
- 21.2 Strong Focus on Manpower and Investments in Research & Development Area
- 21.3 Advanced Technology in the Diagnostics Market
- 21.4 Marketing Channel
- List of Figure s
- Figure 2-1: Global – Cardiac Marker Market (Billion US$), 2011 - 2017
- Figure 2-2: Global – Forecast For Cardiac Marker Market (Billion US$), 2018 – 2024
- Figure 5-1: Worldwide – Alere Cardiology Net Sales (Million US$), 2011 – 2016
- Figure 6-1: Worldwide – Response Biomedical Cardiovascular Product Sales (Million US$), 2011 – 2016
- Figure 7-1: Worldwide – Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 – 2017
- Figure 7-2: Worldwide – Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2018 – 2024
- Figure 8-1: WIFI Set-up
- Figure 8-2: QR CODE VIA BARCODE SCANNER Set-up
- Figure 8-3: QR CODE VIA SMART PHONE APP Set-up
- Figure 8-4: Connectivity of cobas h 232 in pre-hospital care and within hospital Set-up
- Figure 14-1: Worldwide – Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2011 – 2017
- Figure 14-2: Worldwide – Forecast for Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2018 – 2024
- Figure 21-1: Boditech – R&D Manpower, Jan 2016
- Figure 21-2: Boditech – R&D Investments (Million US$), Jan 2016
- List of Tables
- Table 2-1: Cardiac Marker Companies – Comparative Tests Analysis
- Table 2-2: Cardiac Marker Companies – Comparative Tests Analysis
- Table 2-3: Cardiac Marker Companies – Comparative Tests Analysis
- Table 3-1: Cardiac Marker Analyzer – Competitive Product Analysis
- Table 3-2: Cardiac Marker Analyzer – Competitive Product Analysis
- Table 6-1: i-STAT 1 Analyzer Specification
- Table 12-1: PATHFAST – Technical Specifications
- Table 15-1: Mergers, Acquisitions and Licensing Agreements, 2003 - 2017
- Table 18-1: Roche - Centralised and Point of Care Solutions Product Launches, 2017
- Table 18-2: Roche - Molecular Diagnostics Product Launches, 2017
- Table 18-3: Roche - Tissue Diagnostics Product Launches, 2017
- Table 18-4: Roche - Sequencing Product Launches, 2017
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBookOther tasks
